Slone Partners

About Us

With a dedicated focus on the life sciences and healthcare industries, Slone Partners is a premier executive search and talent advisory firm with more than 25 years of success delivering visionary leaders and fractional talent who build and scale amazing organizations. With a nationwide presence and global reach, we specialize in discovering and placing innovative leaders, including world-class Board, C-Suite, and upper management professionals.

 

ACHIEVEMENTS

Recent Placements

Slone Partners

Leadership

8

Our leadership is deeply embedded in the industry and supported by an Advisory Board of experts from every sector that we serve.

Staying at the cutting edge of every change in the market allows us to deliver the right candidates for your business and provide invaluable counsel no matter how unique your needs.

Slone Partners

Solutions And Expertise

Founded in 2000, Slone Partners is a premier executive search firm that specializes in recruitment for companies focused in biotechnology, pharma services, life science tools, diagnostics, genomics, clinical services, medical devices, data and analytics, and food sciences.

Solutions
  • Board/Director Search
  • Executive Recruitment
  • Executive Search
  • Fractional
  • Fractional and Interim Services
  • Fractional Executive
  • On-Demand Recruiting
  • On-Demand Talent Solutions
  • Professional Search
Industries
  • Biotechnology
  • Executive Search
  • Healthcare
  • Healthcare Services
  • Healthtech
  • Hospital Foundations
  • Life Sciences
  • Life Sci./Healthcare
  • Medical Devices
  • Pharmaceuticals
  • Science and Research
Functions
  • Board Members
  • Board of Directors
  • Business Leaders
  • C-Level
  • C-Level Leaders
  • C-Suite
  • Clinical Directors
  • Clinical Operations
  • Director/VP
  • General Counsel
  • Head of Department
  • Healthcare
  • Healthcare Board Placements
  • President
  • SVP
  • Vice President

Slone Partners

News Briefings

Slone Partners Appoints Co-CEO

Life sciences-focused search firm Slone Partners has appointed Eric Fink as co-CEO and managing partner. “Eric is a tremendously talented business strategist who brings significant industry experience and compelling insights to our organization,” said Adam Slone, founder and chairman. “His efforts to establish Slone Partners as a leader in fractional search are creating new opportunities for our company and our

Mastering Senior-Level Job Interviews in Life Sciences and Healthcare

In today’s highly competitive job market, landing a senior-level and/or fractional position in life sciences or healthcare requires more than just a stellar resume. Your qualifications on paper may open the door, but how well you perform in the interview process may determine your fate, according to a new report from life sciences-focused search firm Slone Partners.

Slone Partners Recruits CEO for the Personalized Medicine Coalition

Life sciences-focused search firm Slone Partners has assisted in the recruitment of Amy Nicole Nayar as the new president and CEO of the Personalized Medicine Coalition (PMC) in South Riding, VA. She will begin her tenure on January 1, 2025. “We are excited about this placement as part of our long term partnership with the talented PMC team,” said Leslie Loveless, managing

Slone Partners Launches Fractional Talent Service

Life sciences-focused search firm Slone Partners has launched a new fractional talent service. This new service line is designed to complement the firm’s executive search practice, providing current and new clients access to a network of fractional talent comprised of hundreds of verified seasoned leaders and functional experts. These professionals are available on-demand to fill commercial, clinical development, financial,

Slone Partners

Press Releases

Slone Partners Places Jack Kenny on Board of Directors at OraSure Technologies

SOUTH RIDING, VA. – September 18, 2024 – Slone Partners, a nationwide executive search firm for life sciences and healthcare organizations, has announced the placement of Jack Kenny to the Board of Directors at OraSure Technologies, a leader in point-of-care and home diagnostic tests and sample management solutions. Kenny is the former Chief Executive Officer

Esteemed Biotech and Biopharma Executive Eric Fink Named President and Managing Partner at Slone Partners

New President will focus on strategic growth opportunities and leveraging technology to enhance business operations and client services SOUTH RIDING, VA. – July 23, 2024 – Slone Partners, a nationwide executive search firm for life sciences and healthcare organizations, has announced that respected biotech and biopharma executive Eric Fink has joined the company as President

Respected Executive Recruiting Industry Leader Alicia Montgomery Named Chief Operating Officer at Slone Partners

SOUTH RIDING, VA. – July 10, 2024 – Slone Partners, a nationwide executive search firm for life sciences and healthcare organizations, has named industry leader Alicia Montgomery as Chief Operating Officer (COO). This strategic move aims to bolster the company’s operational capacities and strengthen its valuable relationships with companies, organizations, and candidates. Montgomery possesses more

Slone Partners Places Kurt Gish as Chief Scientific Officer at BioLoomics

Slone Partners, a nationwide executive search firm for life sciences and healthcare organizations, has announced the placement of Kurt Gish Ph.D., as Chief Scientific Officer at BioLoomics, a biotechnology company that targets peptide-antibody chimeras to specific compartments inside of diseased cells. Dr Gish will focus on building the company’s pipeline of lysosomal targeting ADCs in

Slone Partners Places Kevin Eastwood as Chief Business Officer at Arpeggio Biosciences

Industry veteran brings more than 25 years of experience in senior leadership roles SOUTH RIDING, VA. – May 29, 2024 – Slone Partners, a nationwide executive search firm for life sciences and healthcare organizations, has announced the placement of Kevin Eastwood as Chief Business Officer at Arpeggio Biosciences, a preclinical therapeutics company whose technology targets transcriptional dysregulation in disease. Eastwood